サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1379188

出生前・新生児遺伝子検査市場レポート：製品タイプ、スクリーニング、疾患、エンドユーザー、地域別、2023-2028年

Prenatal and Newborn Genetic Testing Market Report by Product Type, Screening, Disease, End User, and Region 2023-2028
出版日: | 発行: IMARC | ページ情報: 英文 147 Pages | 納期: 2～3営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　 詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=147.94円
出生前・新生児遺伝子検査市場レポート：製品タイプ、スクリーニング、疾患、エンドユーザー、地域別、2023-2028年
出版日: 2023年11月02日
発行: IMARC
ページ情報: 英文 147 Pages
納期: 2～3営業日
  • 全表示
  • 概要
  • 図表
  • 目次
概要

概要

世界の出生前・新生児遺伝子検査の市場規模は、2022年に53億米ドルに達しました。今後、IMARC Groupは、同市場が2028年までに112億米ドルに達し、2022年から2028年にかけて13.3%の成長率（CAGR）を示すと予測しています。先進的な診断・スクリーニング機器に対する需要の高まり、世界中の新生児における先天奇形や遺伝子異常の有病率の上昇、医療産業の隆盛などが、市場を牽引する主要因のひとつです。

出生前・新生児遺伝子検査は、血液検査、特定の種類の超音波検査、出生前無細胞DNAスクリーニングで構成され、胎児や新生児の遺伝子構成に関する貴重な洞察を提供します。この検査は、胎児や新生児の遺伝的障害である特定の先天性異常を特定することができます。この検査は、妊婦の両親、ヘルスケア専門家、調査研究者に重要な情報を提供し、乳児の健康と幸福について十分な情報に基づいた判断を可能にします。妊娠中や乳幼児期の遺伝的変異や異常を正確に同定できるようにする一方で、患者の転帰を改善し、医療介入を導くのに役立ちます。また、ダウン症候群、嚢胞性線維症、鎌状赤血球症、フェニルケトン尿症などの様々な先天性疾患の検出にも役立ちます。両親の血液中の様々なタンパク質レベルを分析し、赤ちゃんの染色体数異常のリスクを判断するのに役立つため、出生前・新生児遺伝子検査の需要は世界中で高まっています。

出生前・新生児遺伝子検査市場の動向：

現在、世界中の大衆の間で高度な診断およびスクリーニング機器に対する需要が高まっていることは、市場の成長を支える重要な要因の一つです。また、世界的に新生児の先天奇形や遺伝子異常の有病率が増加しています。これは、医療産業の繁栄とともに、市場の成長を後押ししています。さらに、従来の方法と比較して、高い精度と正確さ、痛みの少なさ、迅速な診断といった様々な利点があるため、非侵襲的な出生前スクリーニング方法に対する需要の高まりが、市場にプラスの影響を与えています。これに加えて、出生前・新生児遺伝子検査の利点に関する個人の意識の高まりは、業界の投資家に有利な成長機会を提供しています。さらに、健康志向の個人の増加による出生前・新生児遺伝子検査に対する需要の高まりが、市場の成長に寄与しています。これとは別に、各国の政府機関は、市民に充実したヘルスケア・サービスを提供するため、ヘルスケア・インフラの改善に注力しています。これに伴い、主な企業は患者の円錐角膜やその他の角膜ジストロフィーのリスクを特定するための遺伝子眼科検査を開発しています。さらに、遺伝性疾患のリスクを検出するための母体血漿中の無細胞DNA検査に対する需要の高まりは、良好な市場見通しをもたらしています。

本レポートで扱う主な質問

  • 世界の出生前・新生児遺伝子検査市場はこれまでどのように推移し、今後数年間はどのように推移するのか？
  • 世界の出生前・新生児遺伝子検査市場における市場促進要因、抑制要因、機会は何か？
  • それぞれの促進要因、抑制要因、機会が世界の出生前・新生児遺伝子検査市場に与える影響は？
  • 主要な地域市場は？
  • 最も魅力的な出生前・新生児遺伝子検査市場はどの国か？
  • 製品タイプ別の市場内訳は？
  • 出生前・新生児遺伝子検査市場で最も魅力的な製品タイプはどれか？
  • スクリーニングに基づく市場内訳は？
  • 出生前・新生児遺伝子検査市場で最も魅力的なスクリーニングはどれか？
  • 疾患別の市場内訳は？
  • 出生前・新生児遺伝子検査市場で最も魅力的な疾患は？
  • エンドユーザー別の市場内訳は？
  • 出生前・新生児遺伝子検査市場で最も魅力的なエンドユーザーはどこか？
  • 世界の出生前・新生児遺伝子検査市場の競合構造は？
  • 世界の出生前・新生児遺伝子検査市場における主要プレイヤー/企業は？

目次

第1章 序文

第2章 調査範囲と調査手法

  • 調査目的
  • 利害関係者
  • データソース
    • 一次情報
    • 二次情報
  • 市場推定
    • ボトムアップアプローチ
    • トップダウンアプローチ
  • 調査手法

第3章 エグゼクティブサマリー

第4章 イントロダクション

  • 概要
  • 主要産業動向

第5章 世界の出生前・新生児遺伝子検査市場

  • 市場概要
  • 市場実績
  • COVID-19の影響
  • 市場予測

第6章 市場内訳：製品タイプ別

  • 消耗品
    • 市場動向
    • 市場予測
  • 機器
    • 市場動向
    • 市場予測

第7章 市場内訳：スクリーニング別

  • 非侵襲的出生前検査
    • 市場動向
    • 市場予測
  • 絨毛膜絨毛サンプリング
    • 市場動向
    • 市場予測
  • 羊水穿刺
    • 市場動向
    • 市場予測
  • 母体血清スクリーニング
    • 市場動向
    • 市場予測

第8章 市場内訳：疾患別

  • ダウン症
    • 市場動向
    • 市場予測
  • フェニルケトン尿症
    • 市場動向
    • 市場予測
  • 嚢胞性線維症
    • 市場動向
    • 市場予測
  • 鎌状赤血球貧血
    • 市場動向
    • 市場予測

第9章 市場内訳：エンドユーザー別

  • 病院
    • 市場動向
    • 市場予測
  • 産科・専門クリニック
    • 市場動向
    • 市場予測
  • 診断センター
    • 市場動向
    • 市場予測

第10章 市場内訳：地域別

  • 北米
    • 米国
      • 市場動向
      • 市場予測
    • カナダ
      • 市場動向
      • 市場予測
  • アジア太平洋
    • 中国
      • 市場動向
      • 市場予測
    • 日本
      • 市場動向
      • 市場予測
    • インド
      • 市場動向
      • 市場予測
    • 韓国
      • 市場動向
      • 市場予測
    • オーストラリア
      • 市場動向
      • 市場予測
    • インドネシア
      • 市場動向
      • 市場予測
    • その他
      • 市場動向
      • 市場予測
  • 欧州
    • ドイツ
      • 市場動向
      • 市場予測
    • フランス
      • 市場動向
      • 市場予測
    • 英国
      • 市場動向
      • 市場予測
    • イタリア
      • 市場動向
      • 市場予測
    • スペイン
      • 市場動向
      • 市場予測
    • ロシア
      • 市場動向
      • 市場予測
    • その他
      • 市場動向
      • 市場予測
  • ラテンアメリカ
    • ブラジル
      • 市場動向
      • 市場予測
    • メキシコ
      • 市場動向
      • 市場予測
    • その他
      • 市場動向
      • 市場予測
  • 中東・アフリカ地域
    • 市場動向
    • 市場内訳：国別
    • 市場予測

第11章 促進要因、抑制要因、機会

  • 市場概要
  • 促進要因
  • 抑制要因
  • 機会

第12章 バリューチェーン分析

第13章 ポーターのファイブフォース分析

  • 概要
  • 買い手の交渉力
  • 供給企業の交渉力
  • 競合の程度
  • 新規参入業者の脅威
  • 代替品の脅威

第14章 価格分析

第15章 競合情勢

  • 市場構造
  • 主要企業
  • 主要企業のプロファイル
    • Abbott Laboratories
    • BGI Group
    • Bio-Rad Laboratories Inc.
    • F. Hoffmann-La Roche AG
    • Illumina Inc.
    • Laboratory Corporation of America Holdings
    • Natera Inc.
    • PerkinElmer Inc.
    • Quest Diagnostics Incorporated
    • Ravgen Inc.
図表

List of Figures

  • Figure 1: Global: Prenatal and Newborn Genetic Testing Market: Major Drivers and Challenges
  • Figure 2: Global: Prenatal and Newborn Genetic Testing Market: Sales Value (in Billion US$), 2017-2022
  • Figure 3: Global: Prenatal and Newborn Genetic Testing Market Forecast: Sales Value (in Billion US$), 2023-2028
  • Figure 4: Global: Prenatal and Newborn Genetic Testing Market: Breakup by Product Type (in %), 2022
  • Figure 5: Global: Prenatal and Newborn Genetic Testing Market: Breakup by Screening (in %), 2022
  • Figure 6: Global: Prenatal and Newborn Genetic Testing Market: Breakup by Disease (in %), 2022
  • Figure 7: Global: Prenatal and Newborn Genetic Testing Market: Breakup by End User (in %), 2022
  • Figure 8: Global: Prenatal and Newborn Genetic Testing Market: Breakup by Region (in %), 2022
  • Figure 9: Global: Prenatal and Newborn Genetic Testing (Consumables) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 10: Global: Prenatal and Newborn Genetic Testing (Consumables) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 11: Global: Prenatal and Newborn Genetic Testing (Instruments) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 12: Global: Prenatal and Newborn Genetic Testing (Instruments) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 13: Global: Prenatal and Newborn Genetic Testing (Non-invasive Prenatal Testing) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 14: Global: Prenatal and Newborn Genetic Testing (Non-invasive Prenatal Testing) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 15: Global: Prenatal and Newborn Genetic Testing (Chorionic Villus Sampling) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 16: Global: Prenatal and Newborn Genetic Testing (Chorionic Villus Sampling) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 17: Global: Prenatal and Newborn Genetic Testing (Amniocentesis) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 18: Global: Prenatal and Newborn Genetic Testing (Amniocentesis) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 19: Global: Prenatal and Newborn Genetic Testing (Maternal Serum Screening) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 20: Global: Prenatal and Newborn Genetic Testing (Maternal Serum Screening) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 21: Global: Prenatal and Newborn Genetic Testing (Downs Syndrome) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 22: Global: Prenatal and Newborn Genetic Testing (Downs Syndrome) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 23: Global: Prenatal and Newborn Genetic Testing (Phenylketonuria) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 24: Global: Prenatal and Newborn Genetic Testing (Phenylketonuria) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 25: Global: Prenatal and Newborn Genetic Testing (Cystic Fibrosis) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 26: Global: Prenatal and Newborn Genetic Testing (Cystic Fibrosis) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 27: Global: Prenatal and Newborn Genetic Testing (Sickle Cell Anemia) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 28: Global: Prenatal and Newborn Genetic Testing (Sickle Cell Anemia) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 29: Global: Prenatal and Newborn Genetic Testing (Hospital) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 30: Global: Prenatal and Newborn Genetic Testing (Hospital) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 31: Global: Prenatal and Newborn Genetic Testing (Maternity and Specialty Clinics) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 32: Global: Prenatal and Newborn Genetic Testing (Maternity and Specialty Clinics) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 33: Global: Prenatal and Newborn Genetic Testing (Diagnostic Centers) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 34: Global: Prenatal and Newborn Genetic Testing (Diagnostic Centers) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 35: North America: Prenatal and Newborn Genetic Testing Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 36: North America: Prenatal and Newborn Genetic Testing Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 37: United States: Prenatal and Newborn Genetic Testing Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 38: United States: Prenatal and Newborn Genetic Testing Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 39: Canada: Prenatal and Newborn Genetic Testing Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 40: Canada: Prenatal and Newborn Genetic Testing Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 41: Asia-Pacific: Prenatal and Newborn Genetic Testing Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 42: Asia-Pacific: Prenatal and Newborn Genetic Testing Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 43: China: Prenatal and Newborn Genetic Testing Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 44: China: Prenatal and Newborn Genetic Testing Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 45: Japan: Prenatal and Newborn Genetic Testing Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 46: Japan: Prenatal and Newborn Genetic Testing Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 47: India: Prenatal and Newborn Genetic Testing Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 48: India: Prenatal and Newborn Genetic Testing Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 49: South Korea: Prenatal and Newborn Genetic Testing Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 50: South Korea: Prenatal and Newborn Genetic Testing Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 51: Australia: Prenatal and Newborn Genetic Testing Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 52: Australia: Prenatal and Newborn Genetic Testing Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 53: Indonesia: Prenatal and Newborn Genetic Testing Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 54: Indonesia: Prenatal and Newborn Genetic Testing Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 55: Others: Prenatal and Newborn Genetic Testing Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 56: Others: Prenatal and Newborn Genetic Testing Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 57: Europe: Prenatal and Newborn Genetic Testing Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 58: Europe: Prenatal and Newborn Genetic Testing Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 59: Germany: Prenatal and Newborn Genetic Testing Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 60: Germany: Prenatal and Newborn Genetic Testing Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 61: France: Prenatal and Newborn Genetic Testing Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 62: France: Prenatal and Newborn Genetic Testing Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 63: United Kingdom: Prenatal and Newborn Genetic Testing Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 64: United Kingdom: Prenatal and Newborn Genetic Testing Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 65: Italy: Prenatal and Newborn Genetic Testing Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 66: Italy: Prenatal and Newborn Genetic Testing Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 67: Spain: Prenatal and Newborn Genetic Testing Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 68: Spain: Prenatal and Newborn Genetic Testing Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 69: Russia: Prenatal and Newborn Genetic Testing Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 70: Russia: Prenatal and Newborn Genetic Testing Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 71: Others: Prenatal and Newborn Genetic Testing Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 72: Others: Prenatal and Newborn Genetic Testing Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 73: Latin America: Prenatal and Newborn Genetic Testing Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 74: Latin America: Prenatal and Newborn Genetic Testing Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 75: Brazil: Prenatal and Newborn Genetic Testing Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 76: Brazil: Prenatal and Newborn Genetic Testing Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 77: Mexico: Prenatal and Newborn Genetic Testing Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 78: Mexico: Prenatal and Newborn Genetic Testing Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 79: Others: Prenatal and Newborn Genetic Testing Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 80: Others: Prenatal and Newborn Genetic Testing Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 81: Middle East and Africa: Prenatal and Newborn Genetic Testing Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 82: Middle East and Africa: Prenatal and Newborn Genetic Testing Market: Breakup by Country (in %), 2022
  • Figure 83: Middle East and Africa: Prenatal and Newborn Genetic Testing Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 84: Global: Prenatal and Newborn Genetic Testing Industry: Drivers, Restraints, and Opportunities
  • Figure 85: Global: Prenatal and Newborn Genetic Testing Industry: Value Chain Analysis
  • Figure 86: Global: Prenatal and Newborn Genetic Testing Industry: Porter's Five Forces Analysis

List of Tables

  • Table 1: Global: Prenatal and Newborn Genetic Testing Market: Key Industry Highlights, 2022 and 2028
  • Table 2: Global: Prenatal and Newborn Genetic Testing Market Forecast: Breakup by Product Type (in Million US$), 2023-2028
  • Table 3: Global: Prenatal and Newborn Genetic Testing Market Forecast: Breakup by Screening (in Million US$), 2023-2028
  • Table 4: Global: Prenatal and Newborn Genetic Testing Market Forecast: Breakup by Disease (in Million US$), 2023-2028
  • Table 5: Global: Prenatal and Newborn Genetic Testing Market Forecast: Breakup by End User (in Million US$), 2023-2028
  • Table 6: Global: Prenatal and Newborn Genetic Testing Market Forecast: Breakup by Region (in Million US$), 2023-2028
  • Table 7: Global: Prenatal and Newborn Genetic Testing Market: Competitive Structure
  • Table 8: Global: Prenatal and Newborn Genetic Testing Market: Key Players
目次
Product Code: SR112023A11196

Abstract

The global prenatal and newborn genetic testing market size reached US$ 5.3 Billion in 2022. Looking forward, IMARC Group expects the market to reach US$ 11.2 Billion by 2028, exhibiting a growth rate (CAGR) of 13.3% during 2022-2028. The growing demand for advanced diagnostic and screening devices, rising prevalence of congenital malformations and genetic abnormalities in newborn babies around the world, and thriving medical industry represent some of the key factors driving the market.

Prenatal and newborn genetic testing comprises blood tests, a specific type of ultrasound, and prenatal cell-free DNA screening that offers invaluable insights into the genetic makeup of unborn babies and newborns. It can identify certain birth defects, many of which are genetic disorders in unborn or newborn babies. It provides critical information to expectant parents, healthcare professionals, and researchers, enabling them to make informed decisions about the health and well-being of infants. It assists in improving patient outcomes and guiding medical interventions while enabling accurate identification of genetic variations and abnormalities during pregnancy and early infancy. It also aids in detecting various congenital conditions, such as Down syndrome, cystic fibrosis, sickle cell disease, and phenylketonuria. As it helps analyze various protein levels in the blood of parents to determine the risk for abnormal chromosome numbers in babies, the demand for prenatal and newborn genetic testing is rising across the globe.

Prenatal and Newborn Genetic Testing Market Trends:

At present, the rising demand for advanced diagnostic and screening devices among the masses across the globe represents one of the key factors supporting the growth of the market. In addition, there is an increase in the prevalence of congenital malformations and genetic abnormalities in newborn babies worldwide. This, along with the thriving medical industry, is propelling the growth of the market. Moreover, the growing demand for non-invasive prenatal screening methods due to their various benefits, such as high accuracy and precision, less pain, and fast diagnosis, as compared to conventional methods, is positively influencing the market. Besides this, the rising awareness among individuals about the benefits of prenatal and newborn genetic testing is offering lucrative growth opportunities to industry investors. Additionally, the escalating demand for prenatal and newborn genetic testing due to the increasing number of health-conscious individuals is contributing to the growth of the market. Apart from this, governing agencies of various countries are focusing on improving healthcare infrastructure to provide enhanced healthcare services to citizens. In line with this, key players are developing genetic eye tests to identify the risk of keratoconus and other corneal dystrophies in patients. Furthermore, the growing demand for cell-free DNA in maternal plasma tests to detect the risk of genetic disorders is offering a favorable market outlook.

Key Market Segmentation:

IMARC Group provides an analysis of the key trends in each segment of the global prenatal and newborn genetic testing market, along with forecasts at the global, regional, and country levels from 2023-2028. Our report has categorized the market based on product type, screening, disease, and end user.

Product Type Insights:

Consumables

Instruments

The report has provided a detailed breakup and analysis of the prenatal and newborn genetic testing market based on the product type. This includes consumables and instruments. According to the report, consumables represented the largest segment.

Screening Insights:

Non-invasive Prenatal Testing

Chorionic Villus Sampling

Amniocentesis

Maternal Serum Screening

A detailed breakup and analysis of the prenatal and newborn genetic testing market based on the screening has also been provided in the report. This includes non-invasive prenatal testing, chorionic villus sampling, amniocentesis, and maternal serum screening. According to the report, non-invasive prenatal testing accounted for the largest market share.

Disease Insights:

Downs Syndrome

Phenylketonuria

Cystic Fibrosis

Sickle Cell Anemia

A detailed breakup and analysis of the prenatal and newborn genetic testing market based on the disease has also been provided in the report. This includes downs syndrome, phenylketonuria, cystic fibrosis, and sickle cell anemia. According to the report, downs syndrome accounted for the largest market share.

End User Insights:

Hospital

Maternity and Specialty Clinics

Diagnostic Centers

A detailed breakup and analysis of the prenatal and newborn genetic testing market based on the end user has also been provided in the report. This includes hospital, maternity and specialty clinics, and diagnostic centers. According to the report, hospital accounted for the largest market share.

Regional Insights:

North America

United States

Canada

Asia Pacific

China

Japan

India

South Korea

Australia

Indonesia

Others

Europe

Germany

France

United Kingdom

Italy

Spain

Russia

Others

Latin America

Brazil

Mexico

Others

Middle East and Africa

The report has also provided a comprehensive analysis of all the major regional markets, which include North America (the United States and Canada); Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others); Europe (Germany, France, the United Kingdom, Italy, Spain, Russia, and others); Latin America (Brazil, Mexico, and others); and the Middle East and Africa. According to the report, North America was the largest market for prenatal and newborn genetic testing. Some of the factors driving the North America prenatal and newborn genetic testing market included the growing number of pregnant women undergoing genetic screening, rising awareness about various inborn genetic diseases, enhanced healthcare infrastructure, etc.

Competitive Landscape:

The report has also provided a comprehensive analysis of the competitive landscape in the global prenatal and newborn genetic testing market. Detailed profiles of all major companies have been provided. Some of the companies covered include Abbott Laboratories, BGI Group, Bio-Rad Laboratories Inc., F. Hoffmann-La Roche AG, Illumina Inc., Laboratory Corporation of America Holdings, Natera Inc., PerkinElmer Inc., Quest Diagnostics Incorporated, Ravgen Inc., etc. Kindly note that this only represents a partial list of companies, and the complete list has been provided in the report.

Key Questions Answered in This Report:

  • How has the global prenatal and newborn genetic testing market performed so far, and how will it perform in the coming years?
  • What are the drivers, restraints, and opportunities in the global prenatal and newborn genetic testing market?
  • What is the impact of each driver, restraint, and opportunity on the global prenatal and newborn genetic testing market?
  • What are the key regional markets?
  • Which countries represent the most attractive prenatal and newborn genetic testing market?
  • What is the breakup of the market based on the product type?
  • Which is the most attractive product type in the prenatal and newborn genetic testing market?
  • What is the breakup of the market based on the screening?
  • Which is the most attractive screening in the prenatal and newborn genetic testing market?
  • What is the breakup of the market based on the disease?
  • Which is the most attractive disease in the prenatal and newborn genetic testing market?
  • What is the breakup of the market based on the end user?
  • Which is the most attractive end user in the prenatal and newborn genetic testing market?
  • What is the competitive structure of the global prenatal and newborn genetic testing market?
  • Who are the key players/companies in the global prenatal and newborn genetic testing market?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global Prenatal and Newborn Genetic Testing Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Impact of COVID-19
  • 5.4 Market Forecast

6 Market Breakup by Product Type

  • 6.1 Consumables
    • 6.1.1 Market Trends
    • 6.1.2 Market Forecast
  • 6.2 Instruments
    • 6.2.1 Market Trends
    • 6.2.2 Market Forecast

7 Market Breakup by Screening

  • 7.1 Non-invasive Prenatal Testing
    • 7.1.1 Market Trends
    • 7.1.2 Market Forecast
  • 7.2 Chorionic Villus Sampling
    • 7.2.1 Market Trends
    • 7.2.2 Market Forecast
  • 7.3 Amniocentesis
    • 7.3.1 Market Trends
    • 7.3.2 Market Forecast
  • 7.4 Maternal Serum Screening
    • 7.4.1 Market Trends
    • 7.4.2 Market Forecast

8 Market Breakup by Disease

  • 8.1 Downs Syndrome
    • 8.1.1 Market Trends
    • 8.1.2 Market Forecast
  • 8.2 Phenylketonuria
    • 8.2.1 Market Trends
    • 8.2.2 Market Forecast
  • 8.3 Cystic Fibrosis
    • 8.3.1 Market Trends
    • 8.3.2 Market Forecast
  • 8.4 Sickle Cell Anemia
    • 8.4.1 Market Trends
    • 8.4.2 Market Forecast

9 Market Breakup by End User

  • 9.1 Hospital
    • 9.1.1 Market Trends
    • 9.1.2 Market Forecast
  • 9.2 Maternity and Specialty Clinics
    • 9.2.1 Market Trends
    • 9.2.2 Market Forecast
  • 9.3 Diagnostic Centers
    • 9.3.1 Market Trends
    • 9.3.2 Market Forecast

10 Market Breakup by Region

  • 10.1 North America
    • 10.1.1 United States
      • 10.1.1.1 Market Trends
      • 10.1.1.2 Market Forecast
    • 10.1.2 Canada
      • 10.1.2.1 Market Trends
      • 10.1.2.2 Market Forecast
  • 10.2 Asia-Pacific
    • 10.2.1 China
      • 10.2.1.1 Market Trends
      • 10.2.1.2 Market Forecast
    • 10.2.2 Japan
      • 10.2.2.1 Market Trends
      • 10.2.2.2 Market Forecast
    • 10.2.3 India
      • 10.2.3.1 Market Trends
      • 10.2.3.2 Market Forecast
    • 10.2.4 South Korea
      • 10.2.4.1 Market Trends
      • 10.2.4.2 Market Forecast
    • 10.2.5 Australia
      • 10.2.5.1 Market Trends
      • 10.2.5.2 Market Forecast
    • 10.2.6 Indonesia
      • 10.2.6.1 Market Trends
      • 10.2.6.2 Market Forecast
    • 10.2.7 Others
      • 10.2.7.1 Market Trends
      • 10.2.7.2 Market Forecast
  • 10.3 Europe
    • 10.3.1 Germany
      • 10.3.1.1 Market Trends
      • 10.3.1.2 Market Forecast
    • 10.3.2 France
      • 10.3.2.1 Market Trends
      • 10.3.2.2 Market Forecast
    • 10.3.3 United Kingdom
      • 10.3.3.1 Market Trends
      • 10.3.3.2 Market Forecast
    • 10.3.4 Italy
      • 10.3.4.1 Market Trends
      • 10.3.4.2 Market Forecast
    • 10.3.5 Spain
      • 10.3.5.1 Market Trends
      • 10.3.5.2 Market Forecast
    • 10.3.6 Russia
      • 10.3.6.1 Market Trends
      • 10.3.6.2 Market Forecast
    • 10.3.7 Others
      • 10.3.7.1 Market Trends
      • 10.3.7.2 Market Forecast
  • 10.4 Latin America
    • 10.4.1 Brazil
      • 10.4.1.1 Market Trends
      • 10.4.1.2 Market Forecast
    • 10.4.2 Mexico
      • 10.4.2.1 Market Trends
      • 10.4.2.2 Market Forecast
    • 10.4.3 Others
      • 10.4.3.1 Market Trends
      • 10.4.3.2 Market Forecast
  • 10.5 Middle East and Africa
    • 10.5.1 Market Trends
    • 10.5.2 Market Breakup by Country
    • 10.5.3 Market Forecast

11 Drivers, Restraints, and Opportunities

  • 11.1 Overview
  • 11.2 Drivers
  • 11.3 Restraints
  • 11.4 Opportunities

12 Value Chain Analysis

13 Porters Five Forces Analysis

  • 13.1 Overview
  • 13.2 Bargaining Power of Buyers
  • 13.3 Bargaining Power of Suppliers
  • 13.4 Degree of Competition
  • 13.5 Threat of New Entrants
  • 13.6 Threat of Substitutes

14 Price Analysis

15 Competitive Landscape

  • 15.1 Market Structure
  • 15.2 Key Players
  • 15.3 Profiles of Key Players
    • 15.3.1 Abbott Laboratories
      • 15.3.1.1 Company Overview
      • 15.3.1.2 Product Portfolio
    • 15.3.2 BGI Group
      • 15.3.2.1 Company Overview
      • 15.3.2.2 Product Portfolio
    • 15.3.3 Bio-Rad Laboratories Inc.
      • 15.3.3.1 Company Overview
      • 15.3.3.2 Product Portfolio
    • 15.3.4 F. Hoffmann-La Roche AG
      • 15.3.4.1 Company Overview
      • 15.3.4.2 Product Portfolio
    • 15.3.5 Illumina Inc.
      • 15.3.5.1 Company Overview
      • 15.3.5.2 Product Portfolio
    • 15.3.6 Laboratory Corporation of America Holdings
      • 15.3.6.1 Company Overview
      • 15.3.6.2 Product Portfolio
    • 15.3.7 Natera Inc.
      • 15.3.7.1 Company Overview
      • 15.3.7.2 Product Portfolio
    • 15.3.8 PerkinElmer Inc.
      • 15.3.8.1 Company Overview
      • 15.3.8.2 Product Portfolio
    • 15.3.9 Quest Diagnostics Incorporated
      • 15.3.9.1 Company Overview
      • 15.3.9.2 Product Portfolio
    • 15.3.10 Ravgen Inc.
      • 15.3.10.1 Company Overview
      • 15.3.10.2 Product Portfolio

Kindly note that this only represents a partial list of companies, and the complete list has been provided in the report.